TrialThe oncologist2010

Continuous Sunitinib treatment in patients with advanced hepatocellular carcinoma: a Swiss Group for Clinical Cancer Research (SAKK) and Swiss Association for the Study of the Liver (SASL) multicenter phase II trial (SAKK 77/06).

Dieter Koeberle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.